Д.Энхжаргал
Loading...
Товч нэр
Д.Энхжаргал
Бүтэн нэр
Доржбал Энхжаргал
Латин нэр
Dorjbal Enkhjargal
Эрдмийн цол
Профессор
Боловсролын зэрэг
Доктор (Ph.D)
Харьяалал
3 results
Now showing 1 - 3 of 3
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Research into Antibacterial Effects of Polysaccharide-Based Microparticles(Scientific Research Publishing, 2023-01-01) ;Enkhtaivan Erdene ;Odonchimeg Munkhjargal ;Nyamkhuu Lkhagva; Background: Due to worldwide increases in the prevalence of antibiotic-resistant bacteria, it is necessary to develop an active drug delivery system that can enable therapeutics to reach their molecular targets. Maintaining the concentration of any drug in the blood at a certain level for a long time is critical in the practice of drug therapy. With the increased frequency of drug use, the blood concentration of drugs exceeds the therapeutic level, leading to toxicity or ineffectiveness. To solve these problems, in recent years, much attention has been given to developing micro/nano preparations by encapsulating biologically active compounds on polymeric carriers. Therefore, we aimed to extract pectin from sea buckthorn peel, prepare microcapsules containing antibiotics, and determine their physical and chemical properties. Methods: Wastes were separated from sea buckthorn under “Medical raw materials Dry fruit of Hippophae rhamnoides MNS 5225:2002”. Pectin was isolated from sea buckthorn waste according to the “method for determination of pectins MNS3080:1981” standard. The degree of esterification was determined according to ISO 7623:2016. Antibiotic encapsulation with coacervates and water-based emulsions was performed. Antibiotic sensitivity was determined by microdilution according to the Clinical Laboratory Standard Institute (МТ100-S27) method. The results were determined between standard strains of Staphylococcus aureus ATCC 29213 and MRSA ATCC 2758 at different dilution concentrations. Result: Pectin is a brown powder with a sour taste and no odor. There was 71.4% esterification of pectin, 8.9% yield, 1.3% free carboxyl group, 3.2% methylated carboxyl group, 4.5% total carboxyl group, 3.5% ash, and 0.1% nitrogen. A study of the antibacterial activity of pectin containing doxycycline hyclate found that the inhibition of bacterial growth was 0.8 times less than that of pure pectin. It was 1 time less than that of doxycycline alone, and 33 times smaller than that of wontaxime when compared to pure pectin. Pectin containing doxycycline hyclate inhibited MRSA growth at a concentration 6 times lower than pure pectin. This was 2 times lower than doxycycline alone, and 8 times lower than wontaxime. Conclusion: Pectin yields 1.3 after 60 minutes of separation at a sediment concentration ratio of 1:1.15 and pH = 2. Pectin itself is antibacterial against MRSA. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Determination of Antimicrobial Activity of Antibiotics Encapsulated in Liposomes(Mongolian National University of Medical Sciences, 2024-03-15) ;Erdene, Enkhtaivan; ; Objective: Antibiotic-resistant infections caused by bacteria are already a serious concern for humanity, and by 2050, they are most likely to overtake all other causes of death. One of the most frequent causes of skin infections is methicillin-resistant Staphylococcus aureus (MRSA), whose resistance to most medications makes treatment challenging. This study aimed to determine the antibacterial activity of liposome-encapsulated doxycycline compared to free doxycycline. Methods: This study was conducted using an experimental design. Our study isolated and purified the phospholipid (PL) fraction from egg yolk. Antibiotics were encapsulated using the freeze-thaw process, and phospholipids were extracted via intermittent evaporation. Finally, the liposome's minimum inhibitory concentration (MIC) was effective against MRSA. Results: Phospholipid fraction isolated from egg yolks with 32% extraction yield of phosphatidylcholine. The thin phase chromatography fraction was phospholipids with a retention factor (Rf) of 0.39. The effectiveness of liposomal doxycycline hyclate over free doxycycline was demonstrated by in vitro tests. Conclusion: The results showed that a liposome containing phosphatidylcholine could be a tremendous topical antimicrobial construct for treating MRSA infections. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Evaluation of Liposome-Encapsulated Vancomycin Against Methicillin-Resistant Staphylococcus aureus(MDPI AG, 2025-02) ;Erdene, Enkhtaivan ;Munkhjargal, Odonchimeg; ; Background/Objectives: Methicillin-resistant Staphylococcus aureus (MRSA) is a global health concern due to its resistance to conventional antibiotics. This study evaluated the efficacy of liposome-encapsulated vancomycin against MRSA using phospholipids extracted from egg yolk. Liposomes were prepared via the freeze-thaw method, yielding vesicles with an average diameter of 157.01 ± 33.04 nm and a polydispersity index (PDI) of 0.0442, indicating uniformity and stability. Antibacterial activity was assessed using the microdilution method. Liposome-encapsulated vancomycin demonstrated complete bacterial growth inhibition (100%) against MRSA ATCC 2758 at dilutions of 101 and 102, compared to only 50% inhibition by free vancomycin at 101. At higher dilutions (103), liposome-encapsulated vancomycin maintained 70% inhibition, whereas free vancomycin was ineffective. In vivo studies using a murine wound infection model revealed that wounds treated with liposome-encapsulated vancomycin achieved superior healing, with complete tissue regeneration observed by day 14. Histological analysis showed reduced inflammation and enhanced tissue recovery in liposome-encapsulated vancomycin-treated groups, compared to fibrosis and persistent necrosis in free vancomycin-treated groups. By enabling sustained drug release and improved bioavailability, liposomal formulations minimized required dosages and systemic toxicity, reducing the risk of resistance development. This study highlights the clinical potential of liposome-encapsulated vancomycin as a scalable, cost-effective treatment for MRSA, particularly in resource-limited settings.Scopus© Citations 8
